Clik here to view.
Boston Scientific ties employee bonuses to overall company performance |...
Boston Scientific reconfigures its employee bonus program to allocate rewards from a single company-side pool, the value of which is tied to the company's overall performance for the year. Boston...
View ArticleClik here to view.
Attesting to Meaningful Use quality measures
By John D. Halamka, MD I was recently asked how eligible professionals should report the Meaningful Use Clinical Quality Measures if there are zero denominators (i.e. you do not have any hypertensives,...
View ArticleClik here to view.
MassDevice.com +3 | The top 3 med-tech stories for March 5, 2012.
Ex-Spectranetics CEO convicted of lying to the feds, med-tech tax repeal efforts lack momentum in the Senate and GMI Ratings adds Boston Scientific to risky bet list. Say hello to MassDevice +3, a...
View ArticleClik here to view.
Med-tech trends: Stryker, Johnson & Johnson, Medtronic, St. Jude and Boston...
MassDevice.com looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of the last month. Click to enlarge MassDevice.com looked at some of the...
View ArticleClik here to view.
First U.S. patient to get stem cell trachea transplant dies
Christopher Lyles, the 1st U.S. patient to receive a trachea transplant grown from stem cells died from unknown causes this month. Christopher Lyles, the 1st U.S. patient and the 2nd worldwide to...
View ArticleClik here to view.
St. Jude's Riata recall evidence of nationwide issue, doc says |...
The problems with St. Jude Medical's Riata lead, which the company eventually recalled, could have been caught earlier if not for lax policies and practices at the FDA, according to Minneapolis Heart...
View ArticleClik here to view.
FBI, FDA, SEC investigate turmoil at AcuNetx
The FBI, the FDA and the SEC are investigation AcuNetx after its former CEO locked the chairman of the board out of its offices. The FBI, the FDA and the SEC are investigating medical device maker...
View ArticleClik here to view.
Edwards warns on trial limits, doc licenses in Medicare's TAVI reimbursement...
Edwards Lifesciences, the only device maker with an replacement valve system on the U.S. market, offered its 2 cents on Medicare's coverage proposal for replacement heart valve procedures using its...
View ArticleClik here to view.
"Exit hangover" casts a pall on private equity | Wall Street Beat
A backlog of private-equity-backed companies waiting for exits and the $400 billion waiting to be spent in North America alone means stiff competition among PE players; also, EndoChoice buys...
View ArticleClik here to view.
Heart docs headed to trial in harassment case?
A lawsuit filed by California cardiologists against a county hospital, claiming that they were persecuted and forced out of their jobs after exposing inadequate patient care, is likely headed to trial...
View ArticleClik here to view.
Steris gets FDA nod to update replacement for troubled System 1 sterilizers
Steris won FDA clearance for a software update to its System IE sterilization devices, which replaced the System 1 sterilizers that the were the focus of a 2-year spat with the FDA. Steris Corp....
View ArticleClik here to view.
Zimmer axes jobs to cut costs ahead of med-tech tax | Personnel Moves
Zimmer plans cuts and outsourcing at its Warsaw, Ind., headquarters partially to offset the impending burden of a 2.3% medical device tax. Zimmer Holdings (NYSE:ZMH) announced layoffs at its Warsaw,...
View ArticleClik here to view.
Consumer group demands PMA for brain stimulation devices
Consumer advocacy group Public Citizen petitions the FDA to require all cranial electrotherapy stimulator devices to submit pre-market approval applications, after an agency panel recommends that the...
View ArticleClik here to view.
Elekta's Q3 sales spike, earnings soar | Earnings Roundup
Elekta's Q3 sales spike, earnings soar; Essilor's 2011 sales, earnings rise; DGT's sales rise, profits soar on divestiture; Q4, 2011 sales slump, losses widen for Stereotaxis; Sales, earning slide for...
View ArticleClik here to view.
MassDevice.com +3 | The top 3 med-tech stories for March 6, 2012.
Zimmer axes jobs ahead of med-tech tax, "Exit hangover" casts a pall on private equity and Minneapolis Heart doc says St. Jude's Riata recall is evidence of a nationwide surveillance problem. Say...
View ArticleClik here to view.
FDA warns Synthes on mishandled device complaints
The FDA warns Synthes on a series of violations, including failure to promptly review, investigate and report complaints and data about potential device defects. Synthes landed in more hot water with...
View ArticleClik here to view.
Mako Surgical meets The Street, shares slip
Mako Surgical's 4th-quarter and 2011 results meet Wall Street's expectations, but share prices slide anyway. Mako Surgical (NSDQ:MAKO) met Wall Street's forecasts for its 4th-quarter and full-year...
View ArticleClik here to view.
St. Jude Medical rebounds after "Greek tragedy" | Wall Street Beat
Shares of St. Jude Medical (NYSE:STJ) clawed back some of the value lost yesterday in what 1 waggish analyst termed a "Greek tragedy." STJ shares closed down 3.3% yesterday at $39.96 when the company...
View ArticleClik here to view.
GE Healthcare announces layoffs in Vermont | MassDevice.com On Call
GE Healthcare cuts more employees from its South Burlington, Vt., facility in order to "increase competitiveness." Updated March 7, 2012, at 1:30 p.m. with comments from GE Healthcare. MASSDEVICE ON...
View ArticleClik here to view.
CDRH head: End substantial equivalence for some 510(k) applications
By Stewart Eisenhart, Emergo Group Center for Devices and Radiological Health (CDRH) director Jeffery Shuren has advocated rejection of 510(k) clearances in instances where applicants' predicate...
View Article
